ORPHA:33069
Dravet syndrome
Also known as: SMEI · Severe myoclonic epilepsy of infancy · Severe myoclonus epilepsy of infancy
Publications
6,681
Trials
51
Interventional, condition-specific
Researchers
1,209
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, developmental and epileptic characterized by onset of intractable that are often febrile, and associated with cognitive and motor impairment.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
6,681 matched papers (5,209 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
51 matched on ClinicalTrials.gov (13 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
6,681
6,681 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
6,681 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
5,209 in the last 10 years · low confidence
Phrase hits: 6,681 · MeSH hits: 0
Who's working on it?
1,209
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Brunklaus A6 papers · 2026
School of Health and Wellbeing, Royal Hospital for Children, University of Glasgow, Glasgow, UK.
Papers in Europe PMC - 02Cross JH6 papers · 2026
UCL NIHR BRC Great Ormond Street Institute of Child Health, London, UK.
Papers in Europe PMC - 03Nabbout R6 papers · 2026
Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Hopital Necker Enfants Malades, Member of European Network EPICARE, INSERM, UMR 1163, Translational Research for Neurological Disorders, Insititut Imagine, Université Paris cité, Paris, France.
Papers in Europe PMC - 04Perry MS6 papers · 2026
Jane and John Justin Institute for Mind Health, Cook Children's Medical Center, Ft. Worth, TX, USA. Electronic address: scott.perry@cookchildrens.org.
Papers in Europe PMC - 05Scheffer IE6 papers · 2026
University of Melbourne, Austin Health and Royal Children's Hospital, Melbourne, Victoria, Australia.
Papers in Europe PMC - 06Striano P6 papers · 2026
Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, "G. Gaslini" Institute, University of Genoa, Genoa, Italy.
Papers in Europe PMC - 07Strzelczyk A6 papers · 2026
Epilepsiezentrum Frankfurt Rhein-Main, Zentrum der Neurologie Und Neurochirurgie, Universitätsmedizin Frankfurt, Goethe-Universität Frankfurt, Frankfurt am Main, Germany.
Papers in Europe PMC - 08Goldberg EM5 papers · 2026
Division of Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.
Papers in Europe PMC - 09
- 10Lal D5 papers · 2026
Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, USA.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
51
interventional trials for this specific condition
51 interventional trials matched this specific condition name; 13 currently recruiting in our sample.
Data as of 27 July 2026
51 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 97.1th percentile).
low confidence · 97.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
51 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07013331·RECRUITING·A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome
Conditions: Epilepsy · Dravet Syndrome · Drug Resistant Epilepsy · Healthy Controls·Matched via name phrase
- NCT06401538·RECRUITING·BMB-101 in Absence Epilepsy and DEE
Conditions: Absence Epilepsy · Jeavons Syndrome · Dravet Syndrome · Lennox Gastaut Syndrome·Matched via name phrase
- NCT06738732·NOT YET RECRUITING·CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome
Conditions: Lennox-Gastaut Syndrome (LGS) · Dravet Syndrome (DS)·Matched via name phrase
- NCT06924827·NOT YET RECRUITING·A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
Conditions: Dravet Syndrome (DS) · Lennox-Gastaut Syndrome (LGS)·Matched via name phrase
- NCT07225231·NOT YET RECRUITING·Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS
Conditions: Dravet Syndrome (DS) · Lennox Gastaut Syndrome (LGS)·Matched via name phrase
- NCT07112365·RECRUITING·The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
Conditions: Dravet Syndrome·Matched via name phrase
- NCT06598449·RECRUITING·Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
Conditions: Dravet Syndrome (DS) · Children Under 2 Years·Matched via name phrase
- NCT06660394·RECRUITING·A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Conditions: Dravet Syndrome·Matched via name phrase
- NCT06872125·RECRUITING·A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Conditions: Dravet Syndrome·Matched via name phrase
- NCT04462770·RECRUITING·A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Conditions: Dravet Syndrome·Matched via name phrase
- NCT07675746·RECRUITING·A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
Conditions: Dravet Syndrome (DS)·Matched via name phrase
- NCT07531745·RECRUITING·ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Conditions: Dravet Syndrome·Matched via name phrase
- NCT05419492·RECRUITING·A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Conditions: Dravet Syndrome·Matched via name phrase
Observational and natural-history studies
19 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05651204·RECRUITING·GABA Biomarkers in Dravet Syndrome
Conditions: Dravet Syndrome·Matched via name phrase
- NCT06504511·RECRUITING·SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom
Conditions: SCN1A · Dravet Syndrome · Epilepsy·Matched via name phrase
- NCT05126914·RECRUITING·Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
Conditions: Epilepsy · West Syndrome · Dravet Syndrome·Matched via name phrase
- NCT07251673·RECRUITING·Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Conditions: Dravet Syndrome·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Dravet syndrome" OR "Severe myoclonic epilepsy of infancy" OR "Severe myoclonic epilepsy of the infancy" OR "Severe myoclonus epilepsy of infancy" OR "Severe myoclonus epilepsy of the infancy"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Dravet syndrome" OR "Severe myoclonic epilepsy of infancy" OR "Severe myoclonic epilepsy of the infancy" OR "Severe myoclonus epilepsy of infancy" OR "Severe myoclonus epilepsy of the infancy"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 51 interventional · 19 observational · 8 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: SMEI
Confidence reasoning
- Preferred label is short or not clearly distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T23:32:02.137Z
